<div>1. Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger
RE, et al. Association between the use of antenatal magnesium sulfate in
preterm labor and adverse health outcomes in infants. American Journal
of Obstetrics and Gynecology 2002;186(6):1111‐8.</div><div>2. Crowther CA, Hiller JE, Doyle LW, Haslam RR for the Australasian
Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative
Group. Effect of magnesium sulfate given for neuroprotection before
preterm birth: a randomized controlled trial. JAMA 2003;290(20):2669‐76.</div><div>3. Marret S, Marpeau L, Zupan‐Simunek V, Eurin D, Lévêque C, Hellot MF,
et al. Magnesium sulfate given before very‐preterm birth to protect
infant brain: the randomized, controlled PREMAG trial. BJOG: an
international journal of obstetrics and gynaecology2007; Vol. 114, issue
3:310‐8.</div><div>4. Magpie Trial Follow Up Study Collaborative Group. The Magpie Trial: a
randomised trial comparing magnesium sulphate with placebo for
pre‐eclampsia. Outcome for children at 18 months. BJOG: an international
journal of obstetrics and gynaecology 2007;114(3):289‐99.</div><div>5. Rouse D, Hirtz D, Thom E, Varner M, Alexander J, Spong C, Mercer B,
Iams J, Wapner R, Sorokin Y, Harper M, Thorp J, Ramin S, Malone F,
Carpenter M, Miodovnik A, Moawad A, O’Sullivan M, Peaceman A, Hankins G,
Langer O, Caritis S, Roberts J. Magnesium sulfate for the prevention of
cerebral palsy. New England Journal of Medicine 2008;359:895‐905.</div>